BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 25008028)

  • 1. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
    Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?
    van der Ploeg IM; Valdés Olmos RA; Kroon BB; Nieweg OE
    Ann Surg Oncol; 2008 May; 15(5):1485-91. PubMed ID: 18324444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
    Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
    Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
    Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
    Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.
    Mozzillo N; Caracò C; Marone U; Di Monta G; Crispo A; Botti G; Montella M; Ascierto PA
    World J Surg Oncol; 2013 Feb; 11():36. PubMed ID: 23379355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Schmitz PI; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
    Ann Surg Oncol; 2011 Nov; 18(12):3300-8. PubMed ID: 21537867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?
    Wevers KP; Bastiaannet E; Poos HP; van Ginkel RJ; Plukker JT; Hoekstra HJ
    Ann Surg Oncol; 2012 Nov; 19(12):3913-8. PubMed ID: 22588472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
    Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.
    Oude Ophuis CM; van Akkooi AC; Hoekstra HJ; Bonenkamp JJ; van Wissen J; Niebling MG; de Wilt JH; van der Hiel B; van de Wiel B; Koljenović S; Grünhagen DJ; Verhoef C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1172-80. PubMed ID: 26014150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.
    Holtkamp LH; Wang S; Wilmott JS; Madore J; Vilain R; Thompson JF; Nieweg OE; Scolyer RA
    Ann Surg Oncol; 2015 Sep; 22(9):2972-7. PubMed ID: 25990968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
    Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
    J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
    Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
    Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the node of Cloquet the sentinel node for the iliac/obturator node group?
    Shen P; Conforti AM; Essner R; Cochran AJ; Turner RR; Morton DL
    Cancer J; 2000; 6(2):93-7. PubMed ID: 11069226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.